摘要: |
NOW THAT MULTIPLE pharmaceutical companies have COVID-19 vaccines ready to go, eyes are locking in on the logistics sector-and for good reason. For starters, there are many challenges related to vaccine distribution, including securing capacity; related temperature-controlled needs (the Pfizer vaccine needs to be kept at -70 Celsius); security concerns; and seasonal challenges. What's more, both Pfizer and Moderna have publicly stated that their respective vaccines are 95% effective, which further increases the onus on efficient logistics and distribution. Timing will also be key, with vice president Mike Pence stating at an early December press conference that when the vaccine is ready to be administered to the first group of Americans that qualify, it will be shipped within 24 hours of approval. |